Vista Pharmaceuticals Ltd.
L24239TG1991PLC012264ActivePublic · Non-govt companyRoC-HyderabadListed
Last updated: 2026-06-08
35
Compliance Health · F
4 / 9 signals passed
Vista Pharmaceuticals Ltd. is a Public Non-govt company company incorporated in 1991 and based in Telangana, India. Vista Pharmaceuticals Ltd. operates in Hina powder, manufacturing (NIC 24239) with authorized capital of ₹15.00 Cr and paid-up capital of ₹7.36 Cr. For 2022-23, the company reported revenue of ₹1.00 Cr and a net loss of ₹5.82 Cr. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
Risk FlagsDirectors not yet extracted · awaiting MGT-7Health F · 35/100AGM 1728d ago · may be overdue
Revenue (latest FY)
₹1.00 Cr
2022-23
PAT (latest FY)
₹-5.82 Cr
Margin -579.6%
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
₹7.36 Cr
49% of authorized
Filings on Record
0
All current
Incorporated
1991
35 years old
State
Telangana
Sector
Hina powder, manufacturing
NIC 24239
Class
Public
Sub-category
Non-govt company
Authorized Capital
₹15.00 Cr
Paid-up Capital
₹7.36 Cr
49% utilized
Members
—
Last AGM
25 Sept 2021
1728d ago
Last Balance Sheet
31 Mar 2021
1906d ago
Latest Filing
—
Registered Email
—
Registered Office
—
VISTA PHARMACEUTICALS LTD.TRACXN · PUBLIC DATA
Brand VISTA PHARMACEUTICALS LTD. · Legal entity Vista Pharmaceuticals Ltd.
VISTA PHARMACEUTICALS LTD. is the legal entity of Vista Pharmaceuticals.
Total Funding
Latest Round
—
Revenue
Valuation
Funding Rounds
—
Employees
24
Stage
—
HQ
—
Founded
1991
Source: Tracxn (public profile) · joined to MCA on CIN L24239TG1991PLC012264
Quick facts
Registered office
—
NIC code
24239
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
Hina powder, manufacturing
ROC
RoC-Hyderabad
Website
—
Class · sub-category
Public · Non-govt company
Incorporation · Last AGM
25 Jan 1991 · 25 Sept 2021
Directors
LockedAD
Anita Desai
Additional Director5.4y · Ahmedabad · DIN 8527543
VS
Vikram Singh Rathore
Whole-time Director6.1y · Ahmedabad · DIN 1273585
PN
Priya Nair
Director3.0y · New Delhi · DIN 3444732
Get the full board of directors
Directors, DINs & appointment history for Vista Pharmaceuticals Ltd..
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 26 Nov 2022 | 29 Nov 2022 | 0d | filed |
Get financial statements & other filing documents
Full MCA filing history for Vista Pharmaceuticals Ltd..
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 665472468 | HDFC Bank Ltd(Bank) | ₹6.85 Cr | 04 Jul 2021 | Open |
| 433793590 | State Bank of India(Bank) | ₹3.19 Cr | 19 Sep 2019 | Satisfied |
| 255220298 | ICICI Bank Ltd(Bank) | ₹21.07 Cr | 12 Mar 2020 | Open |
| 616116353 | HDFC Bank Ltd(Bank) | ₹11.29 Cr | 04 Jul 2023 | Open |
| 805501891 | ICICI Bank Ltd(Bank) | ₹23.93 Cr | 27 Jan 2019 | Open |
See registered charges & lenders
Charge IDs, lenders & amounts for Vista Pharmaceuticals Ltd..
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCARevenue (bars) vs PAT (line) by FY
Revenue PAT
| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2022-23 | — | ||||
| 2020-21 | — | ||||
| 2015-16 | — |
Detailed Financials
3 FYs| Line item | 2022-23 | 2020-21 | 2015-16 |
|---|---|---|---|
| Income statement | |||
| Revenue from operations | |||
| Other income | |||
| Total income | |||
| Total expenses | |||
| Profit before tax | |||
| Profit / (Loss) after tax | |||
| Balance sheet | |||
| Equity / Net worth | |||
| Borrowings | |||
| Current liabilities | |||
| Total liabilities | |||
| Current assets | |||
| Cash & equivalents | |||
| Total assets | |||
| Employees | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2022-23 | -45.0% | — | — | |
| Profit after Tax2022-23 | — | — | — | |
| Net Worth2022-23 | +28.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | +5.03% | — | +6.91% | +2.93% | — | |||
| 2020-21 | -148.86% | -91.78% | -5.74% | -3.71% | 0.55 | |||
| 2022-23 | -579.57% | -20.74% | -15.92% | -10.29% | 0.55 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 33,86,427 | 59.53% |
| Institutional Investors | 2 | 9,61,889 | 16.91% |
| Public & Others | 41 | 13,40,493 | 23.56% |
See the full shareholding pattern
Promoter, institutional & public holding for Vista Pharmaceuticals Ltd..
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
7 peersMetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
Bottom quartile · P0
PAT (latest FY)
Bottom quartile · P0
Employees
—
—
—
—
Paid-up capital
Top quartile · P86
Compliance Health
96
96
96
Bottom quartile · P0
Events & timeline
429 Dec 2020
Umakanth appointed as Director
29 Dec 2020
Divakar Reddy appointed as Director
06 Aug 2018
Umesh appointed as Director
25 Jan 1991
Company incorporated
Vista Pharmaceuticals Ltd. registered with RoC-Hyderabad; year 1991
External data sources
7 plannedGSTIN Registrations
GST portal
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
MSME-1 form
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
AOC-4 schedule
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
CRISIL / ICRA / CARE feeds
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
IP India Trademark Registry
Applied, registered, opposed. Class numbers + status.
Patents
IP India Patent Registry
Applications and grants. Inventor names + filing dates.
Legal Cases
eCourts + Indian Kanoon
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.
FAQs about Vista Pharmaceuticals Ltd.
When was Vista Pharmaceuticals Ltd. incorporated?
Vista Pharmaceuticals Ltd. was incorporated in 1991 (around 25 Jan 1991). Its CIN is L24239TG1991PLC012264 and it is registered with RoC-Hyderabad.
Where is Vista Pharmaceuticals Ltd. located?
Vista Pharmaceuticals Ltd. is headquartered in Telangana.
What sector does Vista Pharmaceuticals Ltd. operate in?
Vista Pharmaceuticals Ltd. operates in the Hina powder, manufacturing sector (NIC code 24239), classified as Non-govt company.
Who are the directors of Vista Pharmaceuticals Ltd.?
Director details for Vista Pharmaceuticals Ltd. have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Vista Pharmaceuticals Ltd.?
Vista Pharmaceuticals Ltd. has authorized capital of ₹15.00 Cr and paid-up capital of ₹7.36 Cr.
Does Vista Pharmaceuticals Ltd. have any open charges?
Vista Pharmaceuticals Ltd. has no open MCA-registered charges on record.
What is Vista Pharmaceuticals Ltd.'s Compliance Health Score?
RegisterKaro's Compliance Health Score for Vista Pharmaceuticals Ltd. is 35/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 4 of 9 signals passed.